Helicobacter Pylori Screening at Sohag University
Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05835076
Collaborator
(none)
80
14
Study Details
Study Description
Brief Summary
Screen of Helicobacter pylori in hyperemesis gravidarum in early pregnancy to detect the impact of the severity of the disease on pregnant women
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
80 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Helicobacter Pylori Screening in Hyperemesis Gravidarum in Early Pregnancy
Anticipated Study Start Date
:
Apr 1, 2023
Anticipated Primary Completion Date
:
Apr 1, 2024
Anticipated Study Completion Date
:
Jun 1, 2024
Outcome Measures
Primary Outcome Measures
- Positive [2 days]
Positive for Helicobacter pylori
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 40 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
- pregnant woman <16wk
Exclusion Criteria:
- pregnant woman >16wks
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Sohag University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Amr Ayman Hassan,
Helicobacter pylori screening in hyperemesis gravidarum in early pregnancy,
Sohag University
ClinicalTrials.gov Identifier:
NCT05835076
Other Study ID Numbers:
- Soh-Med-23-04-03MS
First Posted:
Apr 28, 2023
Last Update Posted:
Apr 28, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No